Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen: Accelerating The Business And Dividend Growth
07:56am, Monday, 29'th Jan 2024
Amgen has delivered a 647% total return since 2011 and maintained a solid 10.04% 5-Year Dividend Growth Rate. Amid short-term product decisions and sales variations driving down operational efficiency
Amgen's Planning to Take a Bite Out of Cancer. Here's What It Means for the Stock.
09:00am, Saturday, 27'th Jan 2024
Amgen is treating cancers using a new therapeutic modality. It's planning on producing a few more therapies in the same vein.
Amgen (AMGN) Outperforms Broader Market: What You Need to Know
06:56pm, Thursday, 25'th Jan 2024
In the latest trading session, Amgen (AMGN) closed at $310.26, marking a +1.56% move from the previous day.
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
05:31pm, Thursday, 25'th Jan 2024
Everyone knows that America has a major obesity problem. Because of this, new anti-obesity drugs are going to generate a great deal of revenue and profits their companies.
5 top healthcare stocks for earnings growth in 2024
07:09am, Thursday, 25'th Jan 2024
Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
06:00am, Thursday, 25'th Jan 2024
Everyone knows that America has a major obesity problem. Because of this, new anti-obesity drugs are going to generate a great deal of revenue and profits their companies.
Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
04:18pm, Monday, 22'nd Jan 2024
Amgen's stock price has surged, driven by strategic acquisitions, a diverse medical portfolio, and a focus on AI innovation, positioning it for substantial long-term growth. Amgen's strong performance
Here's Why Amgen (AMGN) Gained But Lagged the Market Today
06:56pm, Friday, 19'th Jan 2024
Amgen (AMGN) reachead $307.81 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
US FDA revises labeling on Amgen's drug to treat bone loss
10:06am, Friday, 19'th Jan 2024
The U.S. health regulator said on Friday it has revised the prescribing information on Amgen's drug to treat bone loss to include a boxed warning related to risk of severely low calcium level in certa
Amgen (AMGN) Ascends While Market Falls: Some Facts to Note
07:06pm, Wednesday, 17'th Jan 2024
Amgen (AMGN) closed the most recent trading day at $304.08, moving +0.2% from the previous trading session.
Stocks This Week: Buy The Biotech Stocks: Amgen And Gilead
06:00am, Tuesday, 16'th Jan 2024
Two sets of reliable stock market cycles have topped. Technically, the market does not appear as weak as expected.
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 15'th Jan 2024
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Final Trade: AMGN, SAIA, UNH, GDX
06:32pm, Friday, 12'th Jan 2024
The final trades of the day with the Fast Money traders.
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
09:02am, Friday, 12'th Jan 2024
The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
07:34pm, Thursday, 11'th Jan 2024
Amgen (AMGN) reachead $303.10 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.
